Justin Kline to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Justin Kline has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.213
-
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
Score: 0.171
-
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. Leuk Lymphoma. 2021 06; 62(6):1497-1501.
Score: 0.042